Cargando…
Solar Urticaria, a Disease with Many Dark Sides: Is Omalizumab the Right Therapeutic Response? Reflections from a Clinical Case Report
Solar urticaria is a rare type of photodermatosis that significantly reduces the quality of life of the subjects affected, with a risk of anaphylaxis should the entire body be exposed to the sun. Patients are forced to modify and limit their normal activities, and since the symptoms are triggered by...
Autores principales: | De Martinis, Massimo, Sirufo, Maria Maddalena, Ginaldi, Lia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572395/ https://www.ncbi.nlm.nih.gov/pubmed/31231681 http://dx.doi.org/10.1515/med-2019-0042 |
Ejemplares similares
-
Successful Treatment With Omalizumab in a Child With Asthma and Urticaria: A Clinical Case Report
por: Sirufo, Maria Maddalena, et al.
Publicado: (2019) -
Sex differences in the efficacy of omalizumab in the treatment of
chronic spontaneous urticaria
por: Sirufo, Maria Maddalena, et al.
Publicado: (2022) -
Sex, Allergic Diseases and Omalizumab
por: Sirufo, Maria Maddalena, et al.
Publicado: (2022) -
Omalizumab an effective and safe alternative therapy in severe refractory atopic dermatitis: A case report
por: Sirufo, Maria Maddalena, et al.
Publicado: (2018) -
Cholinergic Urticaria, an Effective and Safe “Off Label” Use of Dupilumab: A Case Report with Literature Review
por: Sirufo, Maria Maddalena, et al.
Publicado: (2022)